TD Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-72,648	Closed	-$5.2M	–	1446
2023 Q4	$5.2M	Buy	+72,648	New	+$4.18M	0.01%	756
2020 Q4	–	Sell	-16,916	Closed	-$434K	–	1484
2020 Q3	$434K	Sell	16,916 -6,412	-27%	-$146K	﹤0.01%	1271
2020 Q2	$599K	Sell	23,328 -12,400	-35%	-$251K	﹤0.01%	1181
2020 Q1	$549K	Buy	35,728 +5,728	+19%	+$124K	﹤0.01%	1157
2019 Q4	$1.03M	Buy	+30,000	New	+$360K	﹤0.01%	1085
2019 Q3	–	Sell	-14,900	Closed	-$193K	–	1374
2019 Q2	$193K	Buy	14,900 +700	+5%	+$8.98K	﹤0.01%	1300
2019 Q1	$173K	Hold	14,200	–	–	﹤0.01%	1313
2018 Q4	$162K	Sell	14,200 -6,900	-33%	-$111K	﹤0.01%	1362
2018 Q3	$458K	Sell	21,100 -16,600	-44%	-$347K	﹤0.01%	1308
2018 Q2	$666K	Sell	37,700 -11,400	-23%	-$231K	﹤0.01%	1210
2018 Q1	$1.03M	Buy	+49,100	New	+$956K	﹤0.01%	1051
2017 Q2	–	Sell	-14,000	Closed	-$228K	–	1377
2017 Q1	$228K	Sell	14,000 -1,300	-8%	-$18.8K	﹤0.01%	1356
2016 Q4	$231K	Buy	15,300 +1,100	+8%	+$15.5K	﹤0.01%	1325
2016 Q3	$216K	Buy	+14,200	New	+$574K	﹤0.01%	1355